Unveiling 26 Analyst Insights On Sarepta Therapeutics
Unveiling 26 Analyst Insights On Sarepta Therapeutics
揭示了26個關於sarepta therapeutics的分析師見解
The perception of Sarepta Therapeutics by financial experts is analyzed through...Ratings for Sarepta Therapeutics (NASDAQ:SRPT) were provided by 26 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
在過去三個月中，26位分析師對Sarepta Therapeutics (納斯達克股票代碼：SRPT)進行了評級，展示了看好和看淡兩種觀點的混合態度。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
總結他們最近的評估，下表展示了過去30天內不斷變化的情緒，並將其與之前的幾個月進行了比較。
Analysts have set 12-month price targets for Sarepta Therapeutics, revealing an average target of $188.31, a high estimate of $235.00, and a low estimate of $128.00. This current average reflects an increase of 7.65% from the previous average price target of $174.92.
Analysts have set 12-month price targets for Sarepta Therapeutics, revealing an average target of $188.31, a high estimate of $235.00, and a low estimate of $128.00. This current average reflects an increase of 7.65% from the previous average price target of $174.92.
Deciphering Analyst Ratings: An In-Depth Analysis
分析師評級解讀：深入分析
The perception of Sarepta Therapeutics by financial experts is analyzed through...
通過最近的分析師行動，...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間